Monday, September 9th from 12-1PM EST join presenter Dr. Launette Rieb for this webinar in which she will discuss the upcoming release of the Canadian Guidelines detailing the evidence and best practice recommendations for the prevention, assessment and treatment of opioid use disorder among older adults. To register click here.
Baycrest, in partnership with North East Specialized Geriatric Centre, is recruiting for the Fall 2019 program of "Project ECHO Care of the Elderly Long-Term Care (ECHO COE LTC), a telehealth education program that aims to help primary care providers build capacity in the care of older adults through weekly 60-minute videoconference sessions. The sessions will run weekly from September 10 - December 3, 2019 on Tuesdays from 11am -12pm with the exception of October 1st, 2019. See the pdf flyers for more information. To apply please fill out the form at https://redcap.baycrest.org/redcap/surveys/?s=L9RNFHR3WD
Co-developed with geriatric clinical experts from Ontario, on behalf of the Regional Geriatric Programs of Ontario, the sfCare Learning Series comprises introductory educational modules for clinicians, along with supporting posters and patient handouts on 7 key clinical topics: delirium, mobility, polypharmacy, pain, loneliness, nutrition, and urinary incontinence.
Dr. David Conn provided useful guidance in this presentation for clinicians on preventing the development of BZRA use disorder and optimally assessing and treating older individuals who have developed such a disorder. To watch the recording click here.
June 4, 2019 from 12-1PM EST. Join Meaghan Kemp for this Gerimedrisk presentation. Objectives include to understand trazodone's unique pharmacokinetic profile; to recognize the advantages and disadvantages of trazodone use in various clinical settings; to review considerations for use of trazodone in older adults. Register here.
This Cochrane review sought to assess the effects and common adverse effects of any drug treatment versus placebo for sleep disorders in people with dementia through analyzing relevant randomized controlled trials. 67 pages. Last reviewed May 2019.
This publication discusses a case-crossover study aimed at estimating the association between non-benzodiazepine hypnotic drugs and risk of hip fracture among a nationwide sample of long-stay nursing home residents. 15 pages. Last reviewed May 2019.
Friday May 24th from 12-1PM EST. Join presenter Patrick Jung as he reviews the most current guidelines on hypertension management from Hypertension Canada. An update on more recent evidence on the relationship between hypertension management and cognitive impairment risk found in the Systolic Blood Pressure Intervention Trial (SPRINT) will be shared. Cases will be discussed to emphasize unique considerations in the management of blood pressure in older adults. Register here.
May 6, 2019 from 12-1PM EST. Join presenter Krista L. Lanctot, PhD as she outlines the rational for use of cannabinoids, reviews previous literature assessing the efficacy of THC and related compounds for agitation, and presents results of the most recent trial of a cannabinoid for agitation. Register here.